Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Profit After Tax (2023 - 2025)

Historic Profit After Tax for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to -$43.8 million.

  • CG Oncology's Profit After Tax fell 11469.25% to -$43.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$151.5 million, marking a year-over-year decrease of 10815.98%. This contributed to the annual value of -$88.0 million for FY2024, which is 8112.41% down from last year.
  • Latest data reveals that CG Oncology reported Profit After Tax of -$43.8 million as of Q3 2025, which was down 11469.25% from -$41.4 million recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Profit After Tax registered a high of -$8.7 million during Q1 2023, and its lowest value of -$43.8 million during Q3 2025.
  • Over the past 3 years, CG Oncology's median Profit After Tax value was -$18.9 million (recorded in 2024), while the average stood at -$23.3 million.
  • Per our database at Business Quant, CG Oncology's Profit After Tax crashed by 6276.59% in 2024 and then tumbled by 11916.2% in 2025.
  • Quarter analysis of 3 years shows CG Oncology's Profit After Tax stood at -$16.6 million in 2023, then crashed by 92.07% to -$31.8 million in 2024, then crashed by 37.77% to -$43.8 million in 2025.
  • Its Profit After Tax was -$43.8 million in Q3 2025, compared to -$41.4 million in Q2 2025 and -$34.5 million in Q1 2025.